Literature DB >> 33755785

Adenosine and adenosine receptor-mediated action in coronary microcirculation.

Ying Zhang1, Bernhard Wernly2, Xin Cao1, S Jamal Mustafa3, Yong Tang1,4, Zhichao Zhou5.   

Abstract

Adenosine is an ubiquitous extracellular signaling molecule and plays a fundamental role in the regulation of coronary microcirculation through activation of adenosine receptors (ARs). Adenosine is regulated by various enzymes and nucleoside transporters for its balance between intra- and extracellular compartments. Adenosine-mediated coronary microvascular tone and reactive hyperemia are through receptors mainly involving A2AR activation on both endothelial and smooth muscle cells, but also involving interaction among other ARs. Activation of ARs further stimulates downstream targets of H2O2, KATP, KV and KCa2+ channels leading to coronary vasodilation. An altered adenosine-ARs signaling in coronary microcirculation has been observed in several cardiovascular diseases including hypertension, diabetes, atherosclerosis and ischemic heart disease. Adenosine as a metabolite and its receptors have been studied for its both therapeutic and diagnostic abilities. The present review summarizes important aspects of adenosine metabolism and AR-mediated actions in the coronary microcirculation.

Entities:  

Keywords:  Adenosine; Coronary microcirculation; Diabetes; Extracellular nucleotides; Ischemic heart disease; Purinergic receptor

Mesh:

Substances:

Year:  2021        PMID: 33755785      PMCID: PMC7987637          DOI: 10.1007/s00395-021-00859-7

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  128 in total

1.  Adenosine and maximum coronary vasodilation in humans: myth and misconceptions in the assessment of coronary reserve.

Authors:  Gerd Heusch
Journal:  Basic Res Cardiol       Date:  2010-01       Impact factor: 17.165

2.  Adenosine is not responsible for local metabolic control of coronary blood flow in dogs during exercise.

Authors:  J D Tune; K N Richmond; M W Gorman; R A Olsson; E O Feigl
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-01       Impact factor: 4.733

3.  Sole activation of three luminal adenosine receptor subtypes in different parts of coronary vasculature.

Authors:  Rafael Rubio; Guillermo Ceballos
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-09-19       Impact factor: 4.733

Review 4.  Adenosine improves post-procedural coronary flow but not clinical outcomes in patients with acute coronary syndrome: a meta-analysis of randomized trials.

Authors:  Eliano Pio Navarese; Antonino Buffon; Felicita Andreotti; Paul Alfred Gurbel; Marek Kozinski; Aldona Kubica; Giuseppe Musumeci; Alberto Cremonesi; Luigi Tavazzi; Jacek Kubica; Fausto Castriota
Journal:  Atherosclerosis       Date:  2011-11-09       Impact factor: 5.162

5.  The A2A adenosine receptor mediates coronary vasodilation.

Authors:  L Belardinelli; J C Shryock; S Snowdy; Y Zhang; A Monopoli; G Lozza; E Ongini; R A Olsson; D M Dennis
Journal:  J Pharmacol Exp Ther       Date:  1998-03       Impact factor: 4.030

6.  A1 adenosine receptor negatively modulates coronary reactive hyperemia via counteracting A2A-mediated H2O2 production and KATP opening in isolated mouse hearts.

Authors:  Xueping Zhou; Bunyen Teng; Stephen Tilley; S Jamal Mustafa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-09-16       Impact factor: 4.733

7.  Effects of aging and ischemia on adenosine receptor transcription in mouse myocardium.

Authors:  Kevin J Ashton; Ulrika Nilsson; Laura Willems; Kirsty Holmgren; John P Headrick
Journal:  Biochem Biophys Res Commun       Date:  2003-12-12       Impact factor: 3.575

8.  Role of S-adenosylhomocysteine hydrolase in adenosine metabolism in mammalian heart.

Authors:  J Schrader; W Schütz; H Bardenheuer
Journal:  Biochem J       Date:  1981-04-15       Impact factor: 3.857

Review 9.  Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link!

Authors:  Mario Marzilli; C Noel Bairey Merz; William E Boden; Robert O Bonow; Paola G Capozza; William M Chilian; Anthony N DeMaria; Giacinta Guarini; Alda Huqi; Doralisa Morrone; Manesh R Patel; William S Weintraub
Journal:  J Am Coll Cardiol       Date:  2012-09-11       Impact factor: 24.094

Review 10.  Adenosine and the Cardiovascular System.

Authors:  Allison B Reiss; David Grossfeld; Lora J Kasselman; Heather A Renna; Nicholas A Vernice; Wendy Drewes; Justin Konig; Steven E Carsons; Joshua DeLeon
Journal:  Am J Cardiovasc Drugs       Date:  2019-10       Impact factor: 3.571

View more
  5 in total

Review 1.  Purinergic signaling in myocardial ischemia-reperfusion injury.

Authors:  Yi Zhuang; Mei-Ling Yu; Sheng-Feng Lu
Journal:  Purinergic Signal       Date:  2022-03-07       Impact factor: 3.765

2.  NADPH oxidase 4 contributes to TRPV4-mediated endothelium-dependent vasodilation in human arterioles by regulating protein phosphorylation of TRPV4 channels.

Authors:  Yangjing Xie; Yoshinori Nishijima; Natalya S Zinkevich; Ankush Korishettar; Juan Fang; Angela J Mathison; Michael T Zimmermann; David A Wilcox; David D Gutterman; Yuxian Shen; David X Zhang
Journal:  Basic Res Cardiol       Date:  2022-04-25       Impact factor: 12.416

Review 3.  Purinergic interplay between erythrocytes and platelets in diabetes-associated vascular dysfunction.

Authors:  Zhichao Zhou
Journal:  Purinergic Signal       Date:  2021-08-19       Impact factor: 3.765

4.  Adenosine A2a Receptor Regulates Autophagy Flux and Apoptosis to Alleviate Ischemia-Reperfusion Injury via the cAMP/PKA Signaling Pathway.

Authors:  Yun Xia; Feng He; Mohamed Bassirou Moukeila Yacouba; Huimin Zhou; Jingfan Li; Ying Xiong; Jingjing Zhang; Hui Li; Yanlin Wang; Jianjuan Ke
Journal:  Front Cardiovasc Med       Date:  2022-04-29

Review 5.  Purinergic Signaling in Oral Tissues.

Authors:  Mariachiara Zuccarini; Patricia Giuliani; Maurizio Ronci; Francesco Caciagli; Vanni Caruso; Renata Ciccarelli; Patrizia Di Iorio
Journal:  Int J Mol Sci       Date:  2022-07-14       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.